Moran Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.6M Sell
88,810
-2,093
-2% -$488K 0.62% 36
2026
Q1
$22.2M Buy
90,903
+12,160
+15% +$2.83M 0.68% 28
2025
Q4
$16.3M Sell
78,743
-4,151
-5% -$821K 0.5% 58
2025
Q3
$15.4M Sell
82,894
-16,418
-17% -$2.81M 0.46% 68
2025
Q2
$15.2M Sell
99,312
-1,968
-2% -$303K 0.47% 62
2025
Q1
$16.8M Buy
101,280
+16,115
+19% +$2.52M 0.56% 54
2024
Q4
$12.3M Sell
85,165
-2,349
-3% -$364K 0.39% 88
2024
Q3
$14.2M Sell
87,514
-153
-0.2% -$24.4K 0.44% 79
2024
Q2
$12.8M Buy
87,667
+474
+0.5% +$70.5K 0.42% 80
2024
Q1
$13.8M Buy
87,193
+636
+0.7% +$101K 0.45% 79
2023
Q4
$13.6M Sell
86,557
-5,505
-6% -$844K 0.48% 68
2023
Q3
$14.3M Sell
92,062
-131,177
-59% -$21.6M 0.56% 64
2023
Q2
$37M Buy
223,239
+6,860
+3% +$1.11M 1.39% 6
2023
Q1
$33.5M Buy
216,379
+44,619
+26% +$7.2M 1.27% 9
2022
Q4
$30.3M Buy
+171,760
New +$29.7M 1.15% 15

Other funds holding JNJ

Moran Wealth Management's JNJ Position: Q2 2026 in Review

Moran Wealth Management reduced its Johnson & Johnson (JNJ) stake by 2.3% in Q2 2026, selling an estimated $488K and leaving 88,810 shares worth $22.6M. The position accounts for 0.62% of the portfolio, ranked #36.

Moran Wealth Management first reported a position in JNJ in Q4 2022 and has held it in 15 quarters since. The position peaked at $37M in Q2 2023. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Moran Wealth Management held 88,810 shares of Johnson & Johnson worth $22.6M as of Q2 2026.
  • Moran Wealth Management sold 2,093 Johnson & Johnson shares in Q2 2026, an estimated $488K.
  • Johnson & Johnson made up 0.62% of Moran Wealth Management's portfolio in Q2 2026, its #36 holding.
  • Moran Wealth Management first reported a position in Johnson & Johnson in Q4 2022 and has held it in 15 quarters since.
  • Moran Wealth Management's Johnson & Johnson position peaked at $37M in Q2 2023.
  • 4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Moran Wealth Management's 13F filing for Q2 2026, filed 5 Aug 2026.